ABBV-552 / AbbVie 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ABBV-552 / AbbVie
NCT05771428: Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease

Completed
2
263
Europe, Japan, US, RoW
ABBV-552, Placebo for ABBV-552
AbbVie
Alzheimer's Disease (AD)
08/24
09/24
NCT05686980: A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants

Completed
1
18
US
ABBV-552
AbbVie
Healthy Volunteers
03/23
03/23
NCT06278766: A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration

Completed
1
8
US
ABBV-552
AbbVie
Healthy Volunteer
04/24
04/24

Download Options